Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Coronary Atherosclerosis in T2DM/Metabolic Syndrome
NCT00155350Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in Coronary atherosclerosis (CAD), sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
pioglitazone
03
Conditions
Coronary atherosclerosis (CAD)
Beyond the preview
Go deeper on NCT00155350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00155350.